Tennessee bill targeting pharmacy benefit managers sparks fight with CVS
A bill moving through the Tennessee legislature could reshape how prescription drugs are managed, setting up a clash between lawmakers and one of the largest pharmacy companies in the U.S.
What the bill does
The measure, which supporters and news reports call the FAIR Rx Act, bars pharmacy benefit managers, or PBMs, from holding pharmacy licenses in Tennessee. PBMs are companies that manage prescription drug benefits for insurers and employers. Under the law as reported, PBMs must divest their pharmacy ownership by July 1, 2028, and companies that separate their PBM and pharmacy operations get about six months before the law is fully enforced. The Senate sponsor is Sen. Bobby Harshbarger (R-Kingsport), and the House sponsor is Rep. Rick Scarbrough (R-Oak Ridge). Supporters argued that the measure would stop conflicts of interest and protect independent pharmacies from unfair reimbursement. Reporting on the bill also noted that Harshbarger's family owns an East Tennessee pharmacy.
Why lawmakers acted
Reporting on the bill cites a state audit that found one PBM, CVS Caremark, reimbursed its affiliated pharmacies more than non-affiliated pharmacies for the same medications. One report put that difference at up to 16,000 percent. The Tennessee Pharmacists Association also pointed to audit findings about Express Scripts' spread-pricing revenue. The audit documents have not been reported, and that figure has not been quantified.
CVS's response and the lawsuit
CVS opposed the bill when it passed the General Assembly in April, saying it would lead to pharmacy closures, job losses and reduced access. After the governor signed it, CVS warned that it could close all 134 of its Tennessee pharmacies rather than separate from Caremark, and said it would “exhaust all options” to keep operating. CVS also cited figures that have not been independently verified. They include about 1.5 million Tennesseans who rely on CVS pharmacies, employer cost increases of more than $180 million a year from 2028, and the loss of 25 MinuteClinic locations and more than 2,000 jobs. CVS filed a federal suit in the Middle District of Tennessee challenging the law. The suit argues that the law unfairly targets out-of-state companies, violates the Dormant Commerce Clause, and interferes with nationwide health plans and mail-order pharmacy operations. The exact filing date has not been reported, and reports said CVS's Tennessee stores were open and serving patients.
What is not yet confirmed
The exact signing date and a bill number have not been reported. The ownership rule is also described differently across reports. One describes a ban on pharmacy licenses, while a trade-press summary describes a cap on ownership interest of more than 5 percent in a state pharmacy. The enacted text should be checked before either description is relied on. One report says Arkansas passed a similar law last year and that its enforcement is temporarily blocked while legal challenges continue. The current court status of Tennessee's law.






